Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type

Roberto Franceschi,Riccardo Pertile,Marco Marigliano,Enza Mozzillo,Claudio Maffeis,Elisa Morotti,Francesca Di Candia,Ludovica Fedi,Dario Iafusco,Angela Zanfardino,Vittoria Cauvin,Giulio Maltoni,Stefano Zucchini,Valentino Cherubini,Valentina Tiberi,Nicola Minuto,Marta Bassi,Ivana Rabbone,Silvia Savastio,Davide Tinti,Gianluca Tornese,Riccardo Schiaffini,Stefano Passanisi,Fortunato Lombardo,Riccardo Bonfanti,Andrea Scaramuzza,Alda Troncone,Francesca Di Candia
DOI: https://doi.org/10.1111/dme.15307
IF: 3.5
2024-02-23
Diabetic Medicine
Abstract:Aims While continuous glucose monitoring (CGM) and associated technologies have positive effects on metabolic control in young people with type 1 diabetes (T1D), less is known about their impact on quality of life (QoL). Here, we quantified CGM satisfaction and QoL in young people with T1D and their parents/caregivers to establish (i) the relationship between QoL and CGM satisfaction and (ii) the impact of the treatment regimen on QoL. Methods This was a cross‐sectional study of children and adolescents with T1D on different treatment regimens (multiple daily injections, sensor‐augmented pumps and automated insulin delivery). QoL was assessed with the KINDL instrument, and CGM satisfaction with the CGM‐SAT questionnaire was evaluated in both youths with T1D and their parents. Results Two hundred and ten consecutively enrolled youths with T1D completed the KINDL and CGM‐SAT questionnaires. The mean total KINDL score was greater than neutral in both subjects with T1D (3.99 ± 0.47) and parents (4.06 ± 0.40), and lower overall CGM‐SAT scores (i.e., higher satisfaction) were significantly associated with higher QoL in all six KINDL subscales (p
endocrinology & metabolism
What problem does this paper attempt to address?